MARTINA, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 2.134
EU - Europa 946
AS - Asia 541
SA - Sud America 118
AF - Africa 75
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.818
Nazione #
US - Stati Uniti d'America 2.118
IT - Italia 175
SG - Singapore 172
RU - Federazione Russa 169
CN - Cina 148
IE - Irlanda 147
SE - Svezia 138
HK - Hong Kong 129
BR - Brasile 109
UA - Ucraina 87
CI - Costa d'Avorio 55
DE - Germania 54
FR - Francia 49
GB - Regno Unito 35
TR - Turchia 30
FI - Finlandia 29
DK - Danimarca 26
IN - India 22
KR - Corea 16
MA - Marocco 16
CA - Canada 10
NL - Olanda 10
AT - Austria 9
BE - Belgio 8
JP - Giappone 7
CU - Cuba 4
AU - Australia 3
BD - Bangladesh 3
ES - Italia 3
RO - Romania 3
AM - Armenia 2
CZ - Repubblica Ceca 2
GE - Georgia 2
MX - Messico 2
PY - Paraguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AR - Argentina 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
ID - Indonesia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
SC - Seychelles 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.818
Città #
Chandler 367
Des Moines 323
Dublin 138
Ashburn 134
Hong Kong 128
Boardman 122
Fairfield 117
New York 102
Jacksonville 101
Singapore 96
The Dalles 59
Wilmington 57
Abidjan 54
Lawrence 53
Princeton 53
Woodbridge 53
Seattle 49
Houston 39
Cambridge 37
Centro 35
San Mateo 34
Moscow 30
Turin 24
San Diego 22
Guangzhou 19
Los Angeles 19
Washington 18
London 14
Redmond 14
Pune 13
Shanghai 12
Ann Arbor 11
Beijing 11
Helsinki 9
Munich 9
Toronto 9
Brussels 8
Turku 8
Wuhan 8
Dallas 7
Norwalk 7
São Paulo 7
Ancona 6
Santa Clara 6
Jiaxing 5
Kolkata 5
Rome 5
Creazzo 4
Florence 4
Havana 4
Lunano 4
Vienna 4
Belo Horizonte 3
Boston 3
Boydton 3
Brooklyn 3
Bucharest 3
Civitanova Marche 3
Hangzhou 3
Hounslow 3
Jesi 3
Marche 3
New Bedfont 3
Rio de Janeiro 3
San Francisco 3
Tokyo 3
Trieste 3
Andover 2
Atlanta 2
Charlotte 2
Chiswick 2
Cotia 2
Curitiba 2
Fayetteville 2
Guwahati 2
Hackney 2
Hanover 2
Jinhua 2
Kilburn 2
Macerata 2
Matera 2
Menlo Park 2
Milan 2
Naples 2
Norrköping 2
North Augusta 2
Olomouc 2
Parma 2
Pedro Leopoldo 2
Porto Alegre 2
Rimini 2
San Casciano In Val Di Pesa 2
Tashkent 2
Tbilisi 2
Tolentino 2
Valencia 2
Wandsworth 2
Wuxi 2
Xi'an 2
Yerevan 2
Totale 2.588
Nome #
Adalimumab modulates angiogenesis in psoriatic skin 110
Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature 107
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 98
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 96
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 94
Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel 92
Hidradenitis suppurativa: How to treat with BoNT-A 92
Skin Involvement in SARS-CoV-2 Infection: Case Series 91
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 89
Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial 86
Photoprotection and photodermatitis: a case 85
"BOTULINUM TOXIN IN DERMATOLOGY: A CLINICAL OVERVIEW" 83
Botulinum Toxin Off-Label Use in Dermatology: A Review 83
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 83
Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? 82
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 80
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know 80
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 80
Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. 76
Safety update of etanercept treatment for moderate to severe plaque psoriasis 72
Modern electronic devices: An increasingly common cause of skin disorders in consumers 71
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 69
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 69
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 69
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 68
It is never too late to treat chronic spontaneous urticaria with omalizumab: Real-life data from a multicenter observational study focusing on elderly patients 68
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 68
Primary cutaneous large cell lymphoma CD30+: a case-based review 66
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 65
Topical application of fumaric acid esters improves appearance of nail psoriasis 65
Role of small intestinal bacterial overgrowth and helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis 64
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 64
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 64
Myroxylon pereirae (balsam of Peru): Still worth testing? 63
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 57
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 57
Iperidrosi focale: novità terapeutiche 56
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 56
Acral Leukoderma: Is It Always Vitiligo? 55
Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage 54
Asymptomatic pigmentation of the skin in a child: babywipes, once again 54
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 53
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 52
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 48
Saliva and Oral Diseases 47
Omalizumab in Chronic Urticaria: An Italian Survey. 45
Contact allergy to hydrocortisone 21-acetate in Italy: A SIDAPA multicenter study 45
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 44
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 43
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 40
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019 39
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 38
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 38
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy 38
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 34
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 28
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study 27
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 23
Activated switched memory B cell clusters in chronic spontaneous urticaria are increased in subjects with long disease duration and relapse upon omalizumab discontinuation: Results of the IL-10-OMZ study 22
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study 21
The pharmacological treatment and management of hyperhidrosis 20
Mesenchymal Stem Cells and Psoriasis: Systematic Review 20
Treatment of Axillary Bromhidrosis with Topical 2% Glycopyrronium Bromide Cream: A Prospective, Non-randomized, Open-label Study 20
The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going 16
Hand eczema in Italian patients referred for patch testing: A retrospective SIDAPA study (2016–2023) 16
Preliminary experience with abrocitinib in severe atopic dermatitis 15
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness 15
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 11
Translation and pre-validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ) in Italian 7
Totale 3.946
Categoria #
all - tutte 26.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 0 0 0 0 0 3 27
2020/2021420 32 33 50 11 36 21 34 31 32 35 68 37
2021/2022409 8 56 12 2 35 15 9 31 23 12 121 85
2022/20231.180 78 119 63 97 52 419 0 48 204 5 77 18
2023/2024604 86 11 58 66 86 172 10 16 6 20 11 62
2024/20251.026 150 92 22 26 41 30 103 46 308 86 122 0
Totale 3.946